19:30 , Dec 21, 2018 |  BC Week In Review  |  Company News

Astellas exercises option to acquire Potenza

Astellas Pharma Inc. (Tokyo:4503) exercised an exclusive option under an April 2015 deal and acquired Potenza Therapeutics Inc. (Cambridge, Mass.) (see "Potenza Therapeutics, Astellas Deal" ). Potenza received $164.6 million up front and is eligible...